Supernus Pharmaceuticals, Inc. Stock Chart

Supernus Pharmaceuticals, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Supernus Pharmaceuticals, Inc.

LSE
Market Cap
$2.71B
P/E Ratio
41.89
Shares Out.
56.07M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

www.supernus.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0LB2.GB (0LB2.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart